Select the Industry/ Sector 👉    All Industries

Top Pharmaceuticals & Drugs Industry Companies in India by Market Cap

Company
Analysis-Long & Short Term
Industry
Price (EOD)
MarketCap
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹34,324.9
₹72,938 Cr
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,700.4
₹33,731 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹557.6
₹8,776 Cr
Pharmaceuticals & Drugs
₹944.1
₹8,557 Cr
Pharmaceuticals & Drugs
₹530.1
₹4,838 Cr
Pharmaceuticals & Drugs
₹327.3
₹3,662 Cr
Pharmaceuticals & Drugs
₹119.9
₹3,079 Cr
Pharmaceuticals & Drugs
₹252.0
₹1,227 Cr
Pharmaceuticals & Drugs
₹921.6
₹526 Cr
Pharmaceuticals & Drugs
₹68.8
₹195 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Revenues

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Revenues (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Mild Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,700.4
₹4,648 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹557.6
₹4,118 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : Average
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹530.1
₹2,387 Cr
Pharmaceuticals & Drugs
₹944.1
₹2,115 Cr
Pharmaceuticals & Drugs
₹327.3
₹637 Cr
Pharmaceuticals & Drugs
₹119.9
₹222 Cr
Pharmaceuticals & Drugs
₹252.0
₹73 Cr
Pharmaceuticals & Drugs
₹34,324.9
₹6,409 Cr
Pharmaceuticals & Drugs
₹921.6
₹346 Cr
Pharmaceuticals & Drugs
₹68.8
₹474 Cr

Top Pharmaceuticals & Drugs Industry Companies in India by Net Profit

Company
Analysis-Long & Short Term
Industry
Price (EOD)
Net Profit (TTM)
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹2,700.4
₹920 Cr
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹557.6
₹344 Cr
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : Low
  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Pharmaceuticals & Drugs
₹944.1
₹272 Cr
Pharmaceuticals & Drugs
₹530.1
₹168 Cr
Pharmaceuticals & Drugs
₹119.9
₹145 Cr
Pharmaceuticals & Drugs
₹327.3
₹134 Cr
Pharmaceuticals & Drugs
₹252.0
₹3 Cr
Pharmaceuticals & Drugs
₹34,324.9
₹1,414 Cr
Pharmaceuticals & Drugs
₹921.6
₹17 Cr
Pharmaceuticals & Drugs
₹68.8
₹4 Cr

You may also like the below Video Courses